Fronto-temporal Dementia: Nosology, Neuropsychology, and Neuropathology

doi:10.1006/brcg.1996.0041

Brain and Cognition

Volume 31, Issue 2, July 1996, Pages 176-187

https://doi.org/10.1006/brcg.1996.0041 Get rights and content

Abstract

Fronto-temporal dementia is the commonest clinical manifestation of fronto- temporal lobar atrophy. It is associated with three types of underlying histology: microvacuolation or spongiosus (frontal lobe degeneration type), gliosis with or without inclusion bodies and swollen neurones (Pick-type), and motor neurone disease type. The clinical disorder presents in the presenium, is highly familial and is characterized by profound personality change, social incompetence and stereotypic ritualistic behavior. Language becomes attenuated, culminating in total mutism. Visuo-spatial skills are strikingly preserved. The electroencephalogram is normal and structural and functional imaging reflect fronto-temporal lobar atrophy. In a minority of cases the amyotrophic form of motor neurone disease coexists with fronto-temporal dementia and has a rapid and brief duration of illness. Phenotypic characterization of patients at each level of description: clinical, anatomical, and histological, provides a foundation for the molecular genetic studies which ought to shed light on the etiology of this form of focal cerebral degeneration.

References (0)

Cited by (117)

Neurodegenerative disorders of speech and language: Non-language-dominant diseases
2021, Encyclopedia of Behavioral Neuroscience: Second Edition
Speech and language networks span vast cortical and subcortical regions in the human brain, including putative perisylvian areas but extending well beyond them. Accordingly, relevant functions can be compromised by diverse neural disruptions even in non-language-dominant neurodegenerative diseases (nldNDs) –i.e., conditions that are not primarily typified by speech or language dysfunction. The present chapter offers a systematic overview of this topic, focusing on the three most prevalent nldNDs (Alzheimer's disease, Parkinson's disease, and behavioral variant frontotemporal dementia). In each case, we offer detailed descriptions of spared and impaired skills across speech/language levels (phonetics, phonology, lexico-semantics, morphosyntax, discourse-level processing) and multidimensional accounts of their core neural signatures (including patterns of brain atrophy and tractographic abnormalities as well as alterations in regional activation, functional connectivity, event-related potentials, and oscillatory modulations). Next, we offer a brief contrastive summary of the core patterns in each disease. Finally, we address the main implications of the evidence and the prime challenges facing the field in the immediate future. Briefly, this chapter provides a fine-grained, multimodal, transnosological view of speech and language disruptions beyond the diseases typically associated with them.
Photobiomodulation and Other Light Stimulation Procedures
2017, Rhythmic Stimulation Procedures in Neuromodulation
Selective verbal recognition memory impairments are associated with atrophy of the language network in non-semantic variants of primary progressive aphasia
2017, Neuropsychologia
Primary progressive aphasia (PPA) is clinically defined by an initial loss of language function and preservation of other cognitive abilities, including episodic memory. While PPA primarily affects the left-lateralized perisylvian language network, some clinical neuropsychological tests suggest concurrent initial memory loss. The goal of this study was to test recognition memory of objects and words in the visual and auditory modality to separate language-processing impairments from retentive memory in PPA. Individuals with non-semantic PPA had longer reaction times and higher false alarms for auditory word stimuli compared to visual object stimuli. Moreover, false alarms for auditory word recognition memory were related to cortical thickness within the left inferior frontal gyrus and left temporal pole, while false alarms for visual object recognition memory was related to cortical thickness within the right-temporal pole. This pattern of results suggests that specific vulnerability in processing verbal stimuli can hinder episodic memory in PPA, and provides evidence for differential contributions of the left and right temporal poles in word and object recognition memory.
Face-name memory in Alzheimer's disease
2014, Geriatric Nursing
Citation Excerpt :
Alzheimer's Disease primarily affects the cortex of the brain. Magnetic resonance imaging scans and computed tomography show brain lesions with neuritic plaques, neurofibrillary tangles, and degeneration at the ends of nerve cells.6 Face-name memory demands a sophisticated cognitive process not only because of the complexity and similarity among faces but also because of their arbitrary association with names.
Alzheimer's disease (AD) affects face-name memory, the ability to recognize faces and recall names. Remembering face and name requires a sophisticated cognitive process because of the complexity and similarity among faces and also because of their arbitrary association with names. Assessments of face-name memory can measure episodic and semantic memory performance and are useful for early detection of AD. Improving face-name memory is possible through cognitive interventions targeted to promote procedural memory, which is often preserved until the late stage of AD. This article describes a conceptual model, assessment tools, and strategies for improving face-name memory in persons with AD.
Molecular imaging of dementia
2013, Geriatric Mental Health Care
Citation Excerpt :
At the same time, this pattern also helps to distinguish Parkinson's disease and Lewy body disease from atypical Parkinson diseases where a preserved or only slightly reduced presynaptic dopamine transport is accompanied by a significantly reduced post-synaptic receptor binding. Approximately 20% of the presenile cases of dementia are ascribed to Frontotemporal lobar degeneration (FTLD) (Neary and Snowden, 1996. FTLD is the third most common degenerative dementia in industrialized countries, behind Alzheimer's disease (AD) and dementia with Lewy bodies (Snowden et al., 2002).
The increasing age of the population due to improvements in health care in the past century contributes to an increase in the number of people with dementia. However, with an appropriate support and symptomatic treatment, many patients can continue to have an active life and a good quality of life. Treatment and support work best if they are applied at an early stage and also new disease modifying treatments need to focus on predementia and presymptomatic stages of disease.
This article focuses on the role of molecular neuroimaging biomarkers in the reliable clinical diagnosis of dementia at the earliest possible stage of different forms of dementia like Alzheimer's disease, Dementia with Lewy Bodies and frontotemporal lobar degeneration. These different types of dementia are associated with characteristic patterns of hypometabolism in F-18-FDG PET. These reductions occur already years before the onset of symptoms and are strongly correlated with clinical severity.
Recently developed Amyloid-PET-tracers hold promises to be efficient tools in the near future to depict the earliest stages of AD. They may also serve to directly monitor changes of amyloid load due to new treatment approaches.
Meta-analytic review of memory impairment in behavioral variant frontotemporal dementia
2018, Journal of the International Neuropsychological Society

View all citing articles on Scopus

View full text

Regular ArticleFronto-temporal Dementia: Nosology, Neuropsychology, and Neuropathology

Abstract

Regular Article
Fronto-temporal Dementia: Nosology, Neuropsychology, and Neuropathology